Aubagio ‘slows brain atrophy in RRMS patients’
Aubagio ‘slows brain atrophy in RRMS patients’
Genzyme has announced results from magnetic resonance imaging (MRI) analysis of participants in the Phase III TEMSO clinical trial showing Aubagio was able to slow the loss of brain volume (or atrophy) versus a placebo over two years in patients with relapsing-remitting multiple sclerosis (RRMS)... Read More - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 13531 Views
-
Last post by accordingnature495
-
- 0 Replies
- 1968 Views
-
Last post by NHE
-
- 0 Replies
- 1674 Views
-
Last post by NHE
-
- 4 Replies
- 1632 Views
-
Last post by NHE
-
- 0 Replies
- 1289 Views
-
Last post by NHE
-
- 0 Replies
- 1681 Views
-
Last post by NHE
-
- 0 Replies
- 2116 Views
-
Last post by frodo
-
- 0 Replies
- 2216 Views
-
Last post by NHE
-
- 0 Replies
- 1802 Views
-
Last post by NHE